Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Human Vaccines & Immunotherapeutics|February 4, 2025
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studiesJohn M Hickey, Nitya Sharma, Max Fairlamb, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
The Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture DrugsPeter A Kleindl, Jian Xiong, Asha Hewarathna, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
Comparative Characterization of Crofelemer Samples Using Data Mining and Machine Learning Approaches With Analytical Stability Data SetsMaulik K Nariya, Jae Hyun Kim, Jian Xiong, et al.
Journal of Pharmaceutical Sciences|February 13, 2026
Developability assessments with four mRNA-LNP vaccine formulations comparing mouse immunogenicity, structural attributes, and stability profilesMax Fairlamb, Ozan S Kumru, John M Hickey, et al.
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Vaccine|March 21, 2021
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccineAhd Hamidi, Femke Hoeksema, Pim Velthof, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Human Vaccines & Immunotherapeutics|April 16, 2021
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countriesPrashant Kumar, Ravi S Shukla, Ashaben Patel, et al.
Human Vaccines & Immunotherapeutics|February 4, 2025
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studiesJohn M Hickey, Nitya Sharma, Max Fairlamb, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
The Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture DrugsPeter A Kleindl, Jian Xiong, Asha Hewarathna, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Journal of Pharmaceutical Sciences|July 27, 2017
Comparative Characterization of Crofelemer Samples Using Data Mining and Machine Learning Approaches With Analytical Stability Data SetsMaulik K Nariya, Jae Hyun Kim, Jian Xiong, et al.
Journal of Pharmaceutical Sciences|February 13, 2026
Developability assessments with four mRNA-LNP vaccine formulations comparing mouse immunogenicity, structural attributes, and stability profilesMax Fairlamb, Ozan S Kumru, John M Hickey, et al.
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Vaccine|March 21, 2021
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccineAhd Hamidi, Femke Hoeksema, Pim Velthof, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Pageof 18